Blood Pressure During Rate Control in Patients With Tachycardic Atrial Fibrillation at the Emergency Department
试验速览
- 阶段
- 不适用
- 入组人数
- 140
- 主要终点
- Mean and maximum blood pressure difference between before (baseline) and during/after medication.
研究概览
简要总结
The aim of this study is to analyse blood pressure during rate control therapy in patients with tachycardic atrial fibrillation in a real-world emergency cohort.
详细描述
Atrial fibrillation (AF) is the primary clinical problem in 3.3% to 10.0 % emergency department (ED) admissions. Rate control is an integral part of the management of symptomatic tachycardic AF patients.
According to the recent guidelines beta-blockers, digoxin, the calcium channel blockers diltiazem and verapamil, amiodarone or combination therapy should be considered for rate control. Haemodynamic side-effects in particular hypotension may occur. Heart rate and blood pressure behavior in an ED population during rate control therapy in patients with tachycardic atrial fibrillation will be analysed.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 120 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > 18 years
- •Atrial fibrillation or atrial flutter and heart rate ≥ 110 bpm
- •Indication for rate control
- •Informed consent
排除标准
- •Inclusion criteria not met
结局指标
主要结局
Mean and maximum blood pressure difference between before (baseline) and during/after medication.
时间窗: 20th July 2019 to 20th July 2021
次要结局
未报告次要终点
研究者
Hans Domanovits
Principal Investigator
Medical University of Vienna